HOFSETH BIOCARE ASA: årsregnskap 2020 vs 2019
Grew 17% on revenue, fresh owner capital
approved 2021-03-19; registry 2021-07-14; journal 2021 484302
Summary
What changed
Comparing Årsregnskap 2020 with 2019 for HOFSETH BIOCARE ASA. Revenue 58.50m NOK → 68.71m NOK (+17.5%). Net result -89.21m NOK → -105.28m NOK. Equity 118.79m NOK → 261.6k NOK.
On the constructive side: revenue rose; cash rose; owners injected capital. Pressures included: operating result weakened; net result weakened; equity eroded.
Also worth watching: payroll increased; book investments changed. All figures are taken from the published annual accounts for HOFSETH BIOCARE ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 58.50m NOK to 68.71m NOK (+17.5% YoY). Calculated
-
↑
Cash rose
Bank deposits 92.23m NOK → 171.78m NOK (+86.2% YoY). Calculated
-
↑
Owners injected capital
Paid-in equity rose 326.6k NOK → 248.97m NOK (+248.64m NOK). Reported fact
What deteriorated
-
↓
Operating result weakened
Operating result -75.93m NOK → -91.77m NOK (op. margin -129.8% → -133.6%). Calculated
-
↓
Net result weakened
Net result -89.21m NOK → -105.28m NOK (net margin -152.5% → -153.2%). Calculated
-
↓
Equity eroded
Book equity 118.79m NOK → 261.6k NOK (equity ratio 452.1% → 58.8%). Calculated
-
↓
Current ratio dropped below 1×
Current ratio 1.70× → 0.00× — short-term liabilities now exceed liquid/current assets on the published lines. Calculated
Things to notice
-
·
Payroll increased
Salary cost 23.62m NOK → 36.43m NOK (40% → 53% of revenue). Calculated
-
·
Book investments changed
Investment / intangible book value 21.32m NOK → 26.92m NOK. Reported fact